Background
==========

During the course of a bacterial infection, a rapid identification of causative agents is necessary for the determination of effective treatment options. We developed a method based on a modified broad-range PCR and an oligonucleotide microarray for the simultaneous detection and identification of 19 sepsis-causing pathogens at species level, as well as coagulase-negative staphylococci and *Enterobacteriaceae*at taxon level.

Materials
=========

One hundred and fifty-four positive and 15 negative blood culture samples were collected to evaluate the assay performance. For the analysis, DNA was automatically extracted from the samples.

Methods
=======

The broad-range PCR primer mixture was designed using conservative regions of topoisomerase gene subunits *gyrB*and *ign*from various bacteria. The primer design allowed the use of a novel DNA amplification method producing labeled, single-stranded DNA suitable for microarray hybridization. The probes on the microarray were designed against species-specific or taxon-specific variable regions of the *gyrB*and *ign*genes flanked by the primers. As a microarray platform for the probes, we applied TubeArray that is a microreaction vial containing a microarray at the bottom. To indicate the detection of antimicrobial resistance, we included *mecA*-specific primers and probes in the same assay. Furthermore, the software for automated data analysis was provided.

Results
=======

Comparison of the assay results with the gold standard culturing method revealed sensitivity of 98% and specificity of 93%. When the *mecA*identification was correlated with *Staphylococcus aureus*, *Staphylococcus epidermidis*, and *Staphylococcus*genus detection by the specific probes, accurate information about the association of the *mecA*gene with staphylococci was provided. The results from these 15 samples were in line with the antimicrobial susceptibility testing (oxacillin susceptibility testing).

Conclusion
==========

The results from the method were available 3 hours after the positive blood culture result. Up to 24 samples could be processed simultaneously. The assay therefore provides rapid and reliable data, which can guide antimicrobial treatment decisions in a timely manner. We have further broadened the pathogen panel for the detection of 50 bacterial species; 24 at the species level and at least 26 species at the taxon level. The described panel is now commercially available from Mobidiag Ltd (Helsinki, Finland) under the product name Prove-it™ Bacteria.
